Johnson & Johnson's (JNJ) Pharmaceuticals Business Review is just getting underway (webcast)...

|About: Johnson & Johnson (JNJ)|By:, SA News Editor

Johnson & Johnson's (JNJ) Pharmaceuticals Business Review is just getting underway (webcast) (agenda) (presentation). The company anticipates more than 10 new product filings and 25 significant brand extensions by 2017. Shares -1.2% premarket.